Rational Systematic Characterization and Selection of Adjuvants for HIV Vaccine
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 75N93022R00017
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
Notice details come from SAM.gov. Updated .
Notice text
The purpose of this BAA is to solicit proposals for the Rational Systematic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA) program, which will provide a broad range of services for the investigation of vaccine formulations with HIV immunogens and adjuvants. The government reserves the right to execute a change order to add additional immunogens and adjuvants to research supported under this solicitation when needed in response to emerging and re-emerging disease threats both domestic and foreign on a local or global scale are within scope.
Files
| File | Type | Posted |
|---|---|---|
| R_CASA_Pre_Sol_Notice_1.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Rational Systematic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA) | Award Notice | |
| Rational Systematic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA) | Solicitation | |
| This notice | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity